SEMCAP expands into beauty’s longevity opportunity
SEMCAP is betting that longevity’s next growth story may be found less in the lab and more in the everyday rituals consumers already trust. Longevity has largely been sold to...
Investment briefings
Full year 2024 report on the state of longevity investment: the numbers, the sectors, the top deals, the key players and the outlook for 2025:
Annual longevity investment report 2024
Read now
Longevity Clinics Survey 2025
Read now
Half year 2024 report on the state of longevity investment: the numbers, the sectors, the top deals, and the key players:
First half longevity investment report 2024
Read now
Full year 2023 report on the state of longevity investment: the numbers, the sectors, the top deals, the key players and the outlook for 2024:
Annual longevity investment report 2023
Read now
Longevity Clinics Survey 2023
Read now
Investment review for January to March 2023. “If you’re going through hell, keep going.” Winston Churchill:
Q1 2023: longevity investment report
Read now
Full year 2022 report on the state of longevity investment: the numbers, the sectors, the top deals, the key players and the outlook for 2023:
Annual longevity investment report 2022
Read now
Disease management to disease modification – removing plaque to undo atherosclerosis:
Atherosclerosis
Read now
Leading a new era of personalised, preventative health and optimal aging:
Longevity diagnostics
Read now
Investment news
Rubedo reports positive phase 1 results for RLS-1496
March 27, 2026
EU updates review of blarcamesine from Anavex
March 26, 2026
Cognito and Ochsner launch brain health collaboratory
March 26, 2026
Annovis partners with NeuroRPM on Parkinson’s study
March 25, 2026
Dashboard
Deals 
Briefings
Company alerts
News
Videos
Stock tracker